Replies to post #20580 on ViaDerma Inc (VDRM)

[Mistral]

The IBox section created by Neptune (white background) is very accurate and needs to stay until this lawsuit runs its course. It conveys facts related to ViaDerma, Otiko, links to the two patent-pending application numbers for the same invention, names of competitive products based on the transdermal technology at dispute, and includes written communications from Howard Phillips and Steven Keough.

The patent-pending transdermal dispute and related contracts are subjects of pending litigation. The USPTO has not confirmed abandonment of the IP as a Final Action. An Information Disclosure Statement was submitted November 2016 and is being considered.

The Internet Archive/Way Back Machine screen captures are very important. They prove that Otiko was promoting products based on the transdermal technology at the core of this lawsuit.

The Table of IP that Otiko implies he owns is also very important. Everyone can see the two numbers of the Provisional Applications that Otiko states he submitted.

The table with Distributors is important. It shows that Otiko has a financial interest in each distributor. It provides a link to the registration of BIOGENX and a link to the DOJ article regarding the multi-million dollar tax fraud perpetuated by Otiko's friend, and BIOGENX Owner, Garrett Adams, a named Defendant in this lawsuit.

To be clear, the Addendum signed in January 2017, and added to the 2016 Annual Report with Disclosures as an Exhibit, does not grant new rights to Keough's IP. It is there to clarify and correct the misleading statements made by Otiko in prior financials and news releases.

Can Mistral or another mod please remove the old and incorrect information in the ibox regarding the patents, which were abandoned by Keough, and post the correct one from Phillips, which allow Viaderma to sell Diabecline due to the addendum signed by Otiko. Post the provisional patent numbers held by Viaderma as well.